OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dose selection of novel anticancer drugs: exposing the gap between selected and required doses
Catharina J P Op 't Hoog, Niven Mehra, Marc Maliepaard, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. e340-e351
Closed Access | Times Cited: 4
Catharina J P Op 't Hoog, Niven Mehra, Marc Maliepaard, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 8, pp. e340-e351
Closed Access | Times Cited: 4
Showing 4 citing articles:
Design of a Phase I Drug Combination Study with Adaptive Allocation Based on Dose-Limiting Toxicity Attribution
Nolan A. Wages, Bethany J. Horton, Li Liu, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1038-1038
Open Access | Times Cited: 1
Nolan A. Wages, Bethany J. Horton, Li Liu, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1038-1038
Open Access | Times Cited: 1
Synthesis, characterization and biological evaluation of new thiadiazole derivatives: Antibacterial, antifungal, antioxidant, anticancer, simulation studies
Kamala Raj Sunitha, Smitha M. Nair, Mohamed Hefnawy, et al.
Journal of Molecular Structure (2025), pp. 142332-142332
Closed Access
Kamala Raj Sunitha, Smitha M. Nair, Mohamed Hefnawy, et al.
Journal of Molecular Structure (2025), pp. 142332-142332
Closed Access
Determining the optimal use of approved drugs in oncology
Gauthier Bouche, Duncan C. Gilbert, Matteo Quartagno, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 5, pp. e282-e294
Closed Access
Gauthier Bouche, Duncan C. Gilbert, Matteo Quartagno, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 5, pp. e282-e294
Closed Access
Confronting the problems we had hoped to avoid
Hideo Kunitoh, Tadao Kakizoe
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 10, pp. 1059-1061
Open Access | Times Cited: 1
Hideo Kunitoh, Tadao Kakizoe
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 10, pp. 1059-1061
Open Access | Times Cited: 1
Design, synthesis, and biological evaluation of novel (E)-2-cyano-3-(4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-2-yl) derivatives as potent STAT3-targeting anticolorectal cancer agents
Weiqing Jiang, Pingxian Liu, Zhangxun Zhao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107955-107955
Closed Access
Weiqing Jiang, Pingxian Liu, Zhangxun Zhao, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107955-107955
Closed Access
